The underlying mechanism has been proposed to be mediated by urotensin-II (U-II), a potent vasoconstrictor, whose serum levels are positively associated with hypertension, IR, inflammation and with the clinical outcome of T2D and cardiovascular disease [40–42]. This evidence concerns the gene UTS2 and Hypertension.